| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjuvanticity of stearyl tyrosine on inactivated poliovirus vaccine
|
Landi, S.
|
|
1986
|
4 |
2 |
p. 99-104
6 p.
|
article
|
| 2 |
Antibodies to cholera toxin synthetic peptides of increasing size and their reactivity with related toxins
|
Jacob, Chaim O.
|
|
1986
|
4 |
2 |
p. 95-98
4 p.
|
article
|
| 3 |
Antigenic protein material with adenylate-cyclase activity isolated from Bordetella pertussis and used in vaccines against whooping cough with reduced activity
|
|
|
1986
|
4 |
2 |
p. 132-133
2 p.
|
article
|
| 4 |
Calendar
|
|
|
1986
|
4 |
2 |
p. 136-
1 p.
|
article
|
| 5 |
Cattle (respiratory system) RS virus strain having reduced toxicity suitable for use as vaccine
|
|
|
1986
|
4 |
2 |
p. 134-
1 p.
|
article
|
| 6 |
Cell line for the continuous production of human T-lymphotropic retro viruses HTLV-III for the production of AIDS vaccines and antibody detection
|
|
|
1986
|
4 |
2 |
p. 134-
1 p.
|
article
|
| 7 |
Cleaning up pertussis vaccine
|
Bannatyne, Robert M.
|
|
1986
|
4 |
2 |
p. 91-92
2 p.
|
article
|
| 8 |
Continuous cultivation of bacteria for vaccine production with continuous harvesting using a centrifuge; application to e.g. Bordetella bronchiseptica
|
|
|
1986
|
4 |
2 |
p. 132-
1 p.
|
article
|
| 9 |
Culturing transformed yeast (Saccharomyces cerevisiae) for the production of hepatitis B surface antigen for the production of vaccines
|
|
|
1986
|
4 |
2 |
p. 131-
1 p.
|
article
|
| 10 |
DNA coding for antigenic papilloma virus e.g. HPV 1A polypeptide for use in vaccine production and diagnosis
|
|
|
1986
|
4 |
2 |
p. 133-
1 p.
|
article
|
| 11 |
Early interactions between animal viruses and the host cell: relevance to viral vaccines
|
Patterson, S.
|
|
1986
|
4 |
2 |
p. 79-90
12 p.
|
article
|
| 12 |
Emergence of antirabies vaccine of unknown origin for human treatment in Nigeria
|
Ogunkoya, A.B.
|
|
1986
|
4 |
2 |
p. 77-78
2 p.
|
article
|
| 13 |
Hepatitis B core antigen vaccine
|
|
|
1986
|
4 |
2 |
p. 134-
1 p.
|
article
|
| 14 |
Hepatitis B core antigen vaccine made by recombinant DNA
|
|
|
1986
|
4 |
2 |
p. 134-
1 p.
|
article
|
| 15 |
Hepatitis B vaccine surface antigen isolation from serum
|
|
|
1986
|
4 |
2 |
p. 133-
1 p.
|
article
|
| 16 |
Human lymphoblastoid cell line for hybridoma generation and monoclonal antibody production for tetanus treatment
|
|
|
1986
|
4 |
2 |
p. 132-
1 p.
|
article
|
| 17 |
Immunogenicity of a reduced dose of recombinant hepatitis B vaccine
|
Roumeliotou-Karayannis, A.
|
|
1986
|
4 |
2 |
p. 93-94
2 p.
|
article
|
| 18 |
Influence of the particle size on the adjuvant effect of particulate polymeric adjuvants
|
Kreuter, J.
|
|
1986
|
4 |
2 |
p. 125-129
5 p.
|
article
|
| 19 |
In vitro propagation of group II bird adenovirus for preparation of fowl vaccine; leucocyte cell culture
|
|
|
1986
|
4 |
2 |
p. 131-
1 p.
|
article
|
| 20 |
Live varicella vaccine: the third act?
|
Plotkin, Stanley A.
|
|
1986
|
4 |
2 |
p. 74-
1 p.
|
article
|
| 21 |
Long surviving human influenza vaccine preparation by gene reassortment of a human and bird virus
|
|
|
1986
|
4 |
2 |
p. 133-
1 p.
|
article
|
| 22 |
Lyophilized vaccine containing recombinant hepatitis B virus surface antigen adsorbed onto aluminum gel in the presence of stabilizer
|
|
|
1986
|
4 |
2 |
p. 134-
1 p.
|
article
|
| 23 |
Modified live Sendai virus vaccine diluted by passage through incubated culture medium for providing a cold strain
|
|
|
1986
|
4 |
2 |
p. 134-
1 p.
|
article
|
| 24 |
Multivalent pneumococcal vaccine free from C-polysaccharide; purification of polysaccharide from Streptococcus pneumoniae
|
|
|
1986
|
4 |
2 |
p. 131-
1 p.
|
article
|
| 25 |
New attenuated smallpox vaccine strain prepared from Lister strain by low temperature subculture with reduced side effects
|
|
|
1986
|
4 |
2 |
p. 131-
1 p.
|
article
|
| 26 |
New polypeptide smaller than gonococcal pilin protein useful in vaccines against gonorrhea and for producing antibodies for assay of the pilus protein
|
|
|
1986
|
4 |
2 |
p. 130-
1 p.
|
article
|
| 27 |
New synthetic polypeptides useful as immunogens and in vaccines for preventing infections by leukaemia-associated viruses
|
|
|
1986
|
4 |
2 |
p. 133-134
2 p.
|
article
|
| 28 |
New viral polynucleotide sequences and virus preparations obtained from them useful in vaccine to protect mammal against retro viruses having long terminal repeats especially feline leukaemia virus
|
|
|
1986
|
4 |
2 |
p. 130-
1 p.
|
article
|
| 29 |
Non-A non-B hepatitis surface antigen useful for the preparation of vaccines and methods of use - purification of non-A non-B surface antigens from serum or plasma
|
|
|
1986
|
4 |
2 |
p. 132-
1 p.
|
article
|
| 30 |
Process for producing a hepatitis B infection preventing vaccine
|
|
|
1986
|
4 |
2 |
p. 134-
1 p.
|
article
|
| 31 |
Production of bacterial extracts for the manufacture of vaccines by ultrasonic lysis of ultrafiltered bacterial cells
|
|
|
1986
|
4 |
2 |
p. 132-
1 p.
|
article
|
| 32 |
Production of pseudorabies virus subunit vaccines useful for conferring protection against virus infections and for diagnosis especially with sheep antisera; cloning and expression of glycoprotein genes
|
|
|
1986
|
4 |
2 |
p. 133-
1 p.
|
article
|
| 33 |
Psoralen inactivated double-stranded RNA viral vaccines
|
|
|
1986
|
4 |
2 |
p. 134-
1 p.
|
article
|
| 34 |
Recombinant herpes simplex virus vaccine prepared by the expression of DNA constructs in an eukaryotic host
|
|
|
1986
|
4 |
2 |
p. 130-
1 p.
|
article
|
| 35 |
Recombinant plasmid contains DNA coding for polio virus genome for vaccine production
|
|
|
1986
|
4 |
2 |
p. 133-
1 p.
|
article
|
| 36 |
RNA fingerprinting of South American prototype aphthovirus strains
|
Augéde Mello, P.
|
|
1986
|
4 |
2 |
p. 105-110
6 p.
|
article
|
| 37 |
Serological evaluation of poliomyelitis oral and inactivated vaccines in an urban low-income population at Rio de Janeiro, Brazil
|
Schatzmayr, Hermann G.
|
|
1986
|
4 |
2 |
p. 111-113
3 p.
|
article
|
| 38 |
Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial
|
Alexandrova, G.I.
|
|
1986
|
4 |
2 |
p. 114-118
5 p.
|
article
|
| 39 |
Synthesis of fusion proteins containing antigenic determinants of foot-and-mouth disease virus
|
Broekhuijsen, Martien P.
|
|
1986
|
4 |
2 |
p. 119-124
6 p.
|
article
|
| 40 |
The Herpesviruses Vols 3 and 4
|
Powell, K.L.
|
|
1986
|
4 |
2 |
p. 135-
1 p.
|
article
|
| 41 |
Vaccine against mycoplasma pneumonia containing ricin or abrin as adjuvant
|
|
|
1986
|
4 |
2 |
p. 131-
1 p.
|
article
|
| 42 |
Vaccine and hyperimmune serum against Gram-negative bacteria useful for immunizing mammals and birds against enterotoxin producing strains
|
|
|
1986
|
4 |
2 |
p. 131-132
2 p.
|
article
|
| 43 |
Vaccine compositions
|
|
|
1986
|
4 |
2 |
p. 134-
1 p.
|
article
|
| 44 |
Vaccine containing hepatitis B virus surface antigen; isolation from human plasma
|
|
|
1986
|
4 |
2 |
p. 130-
1 p.
|
article
|
| 45 |
Vaccines against urinary tract infections containing new Escherichia coli Gal-Gal pilus protein or fragments
|
|
|
1986
|
4 |
2 |
p. 132-
1 p.
|
article
|
| 46 |
Vaccines made from recombinant yeast cells
|
Hilleman, Maurice R.
|
|
1986
|
4 |
2 |
p. 75-76
2 p.
|
article
|
| 47 |
Vaccinia virus containing DNA coding for rabies glycoprotein useful as vaccine and for the production of the glycoprotein and antisera
|
|
|
1986
|
4 |
2 |
p. 134-
1 p.
|
article
|
| 48 |
Viral clone of Marek disease virus of bird herpes virus serotype 1 useful for fowl protection
|
|
|
1986
|
4 |
2 |
p. 130-
1 p.
|
article
|
Journal description